FT商学院

Silicon Valley still believes in easy blood tests despite Theranos scandal
硅谷仍然相信简单的血液测试

Investors have poured more than $200m into developing a small device in the past year alone
仅在过去一年,投资者就投入了逾2亿美元用于开发一款小型的血液检测设备,Theranos的丑闻并未令其他创业者放弃。

Silicon Valley still believes it can build a computer that can diagnose medical problems from drops of blood, even as the founder of failed start-up Theranos appeared in court this week on charges of defrauding investors with such a vision.

硅谷仍然相信它能制造出一台能够通过血滴诊断医疗问题的计算机,尽管失败的初创公司Theranos的创始人本周出庭,被控以这种愿景欺骗投资者。

您已阅读3%(309字),剩余97%(8682字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×